Jonathan Zager, MD, spoke about the use of observation vs systemic immunotherapy to treat patients with stage IIIA and IIIB melanoma.
Health Professionals
Model for Predicting Recurrence-Free and Melanoma-Specific Survival After SLNB in Melanoma
In a study reported in The Lancet Oncology, Stassen et al developed a model for the prediction of recurrence-free and melanoma-specific survival after sentinel lymph node biopsy (SLNB) in patients with melanoma.
New Vaccine Improves Survival Among Patients with Melanoma
A vaccine developer discusses a cancer vaccine that has been shown to potentially boost long-term overall postsurgical survival.
Untreated obstructive sleep apnea raises risk for poor prognosis in melanoma
The risk for death, melanoma recurrence or metastasis was high among patients with this cancer and untreated obstructive sleep apnea vs. no sleep apnea.